Charles River Laboratories International

Recent executive movements at Charles River Laboratories International

George Llado has joined the company as Director  (news posted on October 16 2020).

Create an alert
to follow the executive moves at Charles River Laboratories International.

Charles River Laboratories International is one of the...

• Fortune 500 (#855);
• Russell 3000.

Most searched biographies at Charles River Laboratories International

• James Foster, Chairman of the Board, President, Chief Executive Of...
• Martin Mackay, Director
• Deborah Kochevar, Director

Click on an executive to view his biography >

Latest M&A news in Biotechnology.

Roivant Sciences has announced the acquisition of Silicon Therapeutics (posted on Feb 26, 2021).
Merck has announced the acquisition of Pandion Therapeutics (posted on Feb 26, 2021).
Charles River Laboratories International has announced the acquisition of Cognate BioServices (posted on Feb 18, 2021).

Other contacts in the Biotechnology industry

• Tal Zaks - Non-Executive Director at Adaptimmune Therapeutics
• Chandra Leo - Director at Gynesonics
• Stephen Hoge - Director at Axcella Health

Learn more about the Biotechnology industry >

Latest news about Charles River Laboratories International

Blowing Bubbles, Depression Treatment

Charles River Laboratories International on Wikipedia, Google News & Yahoo Finance

Charles River Laboratories International on LinkedIn, Twitter & YouTube

Charles River Laboratories International has 1,566 competitors including Biogen (United States (USA)), Neptune Wellness Solutions (Canada) and Eurofins (France).

Contact by email its executives including Deborah Kochevar

Call Charles River Laboratories International at +1 781....

View the org chart

Register to receive your alert

Report an error